Dr. Funchain is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Palo Alto, CA 94304Phone+1 650-723-4000
Education & Training
Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2009 - 2012
Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 2006 - 2009
Ohio State University College of MedicineClass of 2006
Certifications & Licensure
CA State Medical License 2023 - 2025
OH State Medical License 2009 - 2025- American Board of Internal Medicine Medical Oncology
Clinical Trials
Publications & Presentations
PubMed
- Germline Pathogenic Variant (gPV) Positive Patients with Melanoma Exhibit Improved Response to Checkpoint Inhibitor Immunotherapy.Alan Shen, Michelle Arbesman, Roshan Lodha, Patricia Rayman, Brian Gastman
The Journal of Investigative Dermatology. 2025-01-13 - Patterns in progression from early-stage melanoma to late-stage melanoma: implications for survivorship follow-up.David J Savage, Benjamin Switzer, Rujul Parikh, Jung Min Song, Carolyn Stanek
Melanoma Management. 2024-12-01 - Retrospective analysis of immunotherapy outcomes in Black patients.Kerry L Reynolds, Pauline Funchain
The Lancet. Oncology. 2024-12-01
Press Mentions
Inherited Risk May Play a Larger Role in Melanoma Than Previously BelievedJune 20th, 2024- Inherited Genes Play a Larger Role in Melanoma Risk Than Previously BelievedMay 23rd, 2024
- Here’s What Skin Cancer Looks like, Dermatologists Say — Eat This Not ThatApril 9th, 2022
- Join now to see all
Other Languages
- Thai
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
